相似文献
1
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.
Science. 2015 Nov 27;350(6264):1079-84. doi: 10.1126/science.aad1329. Epub 2015 Nov 5.
2
IMMUNOTHERAPY. Could microbial therapy boost cancer immunotherapy?
Science. 2015 Nov 27;350(6264):1031-2. doi: 10.1126/science.aad7706.
3
Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity in mice.
J Immunother. 2015 Feb-Mar;38(2):54-61. doi: 10.1097/CJI.0000000000000064.
4
Tumour immunology: Intestinal bacteria are in command.
Nat Rev Immunol. 2016 Jan;16(1):5. doi: 10.1038/nri.2015.13. Epub 2015 Dec 14.
5
Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.
Cell Res. 2015 Feb;25(2):208-24. doi: 10.1038/cr.2015.3. Epub 2015 Jan 13.
6
Immunotherapy for malignant melanoma.
Curr Stem Cell Res Ther. 2012 May;7(3):217-28. doi: 10.2174/157488812799859883.
7
Combined immunotherapy: CTLA-4 blockade potentiates anti-tumor response induced by transcutaneous immunization.
J Dermatol Sci. 2017 Sep;87(3):300-306. doi: 10.1016/j.jdermsci.2017.06.013. Epub 2017 Jun 16.
8
Therapeutic use of anti-CTLA-4 antibodies.
Int Immunol. 2015 Jan;27(1):3-10. doi: 10.1093/intimm/dxu076. Epub 2014 Jul 18.
9
Ipilimumab targeting CD28-CTLA-4 axis: new hope in the treatment of melanoma.
Curr Top Med Chem. 2012;12(1):61-6. doi: 10.2174/156802612798919231.
10
Ipilimumab (Yervoy) and the TGN1412 catastrophe.
Immunobiology. 2012 Jun;217(6):583-9. doi: 10.1016/j.imbio.2011.07.005. Epub 2011 Jul 7.
引用本文的文献
1
Harnessing biomarkers to guide immunotherapy in esophageal cancer: toward precision oncology.
Clin Transl Oncol. 2025 Sep 6. doi: 10.1007/s12094-025-04051-4.
2
The gut microbiota protein BOC1 exhibits immune checkpoint inhibitor-like activity by inhibiting myeloid-derived suppressor cell differentiation.
Front Immunol. 2025 Aug 19;16:1607543. doi: 10.3389/fimmu.2025.1607543. eCollection 2025.
3
Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors.
NPJ Biofilms Microbiomes. 2025 Sep 2;11(1):180. doi: 10.1038/s41522-025-00819-2.
4
Global research trends on the relationship between gut microbiota and melanoma from 2014 to 2023: a bibliometric and visualization analysis.
Front Microbiol. 2025 Aug 13;16:1524462. doi: 10.3389/fmicb.2025.1524462. eCollection 2025.
5
Harnessing the Gut Microbiome in Cancer Immunotherapy: Mechanisms, Challenges, and Routes to Personalized Medicine-A Systematic Review.
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251365700. doi: 10.1177/15330338251365700. Epub 2025 Aug 28.
6
Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities.
J Exp Clin Cancer Res. 2025 Aug 23;44(1):250. doi: 10.1186/s13046-025-03519-z.
7
Oral microbiota: Roles and treatment in radiation injury (Review).
Oncol Lett. 2025 Aug 8;30(4):472. doi: 10.3892/ol.2025.15218. eCollection 2025 Oct.
8
Phase 1/2, open-label study of oral bacterial supplementation (EDP1503) plus pembrolizumab in participants with advanced or metastatic microsatellite-stable colorectal cancer, triple-negative breast cancer, and checkpoint inhibitor-relapsed tumors.
Invest New Drugs. 2025 Aug 20. doi: 10.1007/s10637-025-01573-0.
9
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity.
Cancer Immunol Immunother. 2025 Aug 19;74(9):289. doi: 10.1007/s00262-025-04111-2.
10
Vitamin D, Gut Microbiota, and Cancer Immunotherapy-A Potentially Effective Crosstalk.
Int J Mol Sci. 2025 Jul 22;26(15):7052. doi: 10.3390/ijms26157052.
本文引用的文献
1
Programming a Human Commensal Bacterium, , to Sense and Respond to Stimuli in the Murine Gut Microbiota.
Cell Syst. 2015 Jul 29;1(1):62-71. doi: 10.1016/j.cels.2015.06.001.
2
A 3-D enteroid-based model to study T-cell and epithelial cell interaction.
J Immunol Methods. 2015 Jun;421:89-95. doi: 10.1016/j.jim.2015.03.014. Epub 2015 Apr 2.
3
Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome.
Nature. 2014 Sep 11;513(7517):237-41. doi: 10.1038/nature13449. Epub 2014 Jun 11.
4
Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms.
Cell Host Microbe. 2014 Apr 9;15(4):413-23. doi: 10.1016/j.chom.2014.03.006.
5
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.
Science. 2013 Nov 22;342(6161):971-6. doi: 10.1126/science.1240537.
6
Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota.
Nature. 2013 May 9;497(7448):258-62. doi: 10.1038/nature12079. Epub 2013 Apr 28.
7
The human commensal Bacteroides fragilis binds intestinal mucin.
Anaerobe. 2011 Aug;17(4):137-41. doi: 10.1016/j.anaerobe.2011.05.017. Epub 2011 Jun 2.
8
Enterotypes of the human gut microbiome.
Nature. 2011 May 12;473(7346):174-80. doi: 10.1038/nature09944. Epub 2011 Apr 20.
9
10
The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.
Sci Transl Med. 2010 Aug 18;2(45):45ra59. doi: 10.1126/scitranslmed.3001270.
Zotero 插件